Michael R. Marco

1.2k total citations
12 papers, 235 citations indexed

About

Michael R. Marco is a scholar working on Oncology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Michael R. Marco has authored 12 papers receiving a total of 235 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Michael R. Marco's work include Colorectal Cancer Treatments and Studies (4 papers), Colorectal Cancer Surgical Treatments (3 papers) and Colorectal and Anal Carcinomas (2 papers). Michael R. Marco is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Colorectal Cancer Surgical Treatments (3 papers) and Colorectal and Anal Carcinomas (2 papers). Michael R. Marco collaborates with scholars based in United States, South Africa and Italy. Michael R. Marco's co-authors include Raphael Pelossof, Julio García‐Aguilar, Steven R. Hunt, Neil Hyman, Jorge Marcet, Charles A. Ternent, Samuel Oommen, Blasé N. Polite, Alessio Pigazzi and Michael J. Stamos and has published in prestigious journals such as Journal of Clinical Oncology, Diseases of the Colon & Rectum and Surgical Endoscopy.

In The Last Decade

Michael R. Marco

11 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Marco United States	8	144	107	37	35	26	12	235
Marta Parera Spain	8	154 1.1×	111 1.0×	22 0.6×	21 0.6×	71 2.7×	9	322
Marga Lang-Welzenbach Germany	5	125 0.9×	59 0.6×	36 1.0×	17 0.5×	28 1.1×	9	207
Gitte‐Bettina Nyvang Denmark	7	93 0.6×	115 1.1×	46 1.2×	37 1.1×	31 1.2×	10	303
Douglas Filipenko Canada	9	111 0.8×	76 0.7×	34 0.9×	8 0.2×	52 2.0×	17	314
Yecai Huang China	10	87 0.6×	56 0.5×	63 1.7×	55 1.6×	97 3.7×	34	289
Ibrahim Azar United States	9	135 0.9×	32 0.3×	76 2.1×	13 0.4×	45 1.7×	24	236
Fraser R. Duthie United Kingdom	9	156 1.1×	94 0.9×	28 0.8×	35 1.0×	50 1.9×	21	211
Maridi Aerts Belgium	8	75 0.5×	89 0.8×	60 1.6×	30 0.9×	88 3.4×	26	256
Shree Venkat United States	10	92 0.6×	91 0.9×	89 2.4×	62 1.8×	91 3.5×	25	398
Malin Sternby Eilard Sweden	10	129 0.9×	75 0.7×	81 2.2×	21 0.6×	45 1.7×	27	314

Countries citing papers authored by Michael R. Marco

Since Specialization

Citations

This map shows the geographic impact of Michael R. Marco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Marco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Marco more than expected).

Fields of papers citing papers by Michael R. Marco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Marco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Marco. The network helps show where Michael R. Marco may publish in the future.

Co-authorship network of co-authors of Michael R. Marco

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Marco. A scholar is included among the top collaborators of Michael R. Marco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Marco. Michael R. Marco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Choi, Seo‐Hyun, Jin K. Kim, Chin‐Tung Chen, et al.. (2022). KRAS Mutants Upregulate Integrin β4 to Promote Invasion and Metastasis in Colorectal Cancer. Molecular Cancer Research. 20(8). 1305–1319. 9 indexed citations

Marco, Michael R., et al.. (2022). Environmental, Social, and Governance Factors in Emerging Markets: a Volatility Study. Review of Economics and Finance. 20. 704–715. 2 indexed citations

Szeglin, Bryan, Chao Wu, Michael R. Marco, et al.. (2021). A SMAD4 ‐modulated gene profile predicts disease‐free survival in stage II and III colorectal cancer. Cancer Reports. 5(1). e1423–e1423. 18 indexed citations

Horvat, Natally, Harini Veeraraghavan, Raphael Pelossof, et al.. (2019). Radiogenomics of rectal adenocarcinoma in the era of precision medicine: A pilot study of associations between qualitative and quantitative MRI imaging features and genetic mutations. European Journal of Radiology. 113. 174–181. 31 indexed citations

Marco, Michael R., et al.. (2019). A KRAS mutation is associated with an immunosuppressive tumor microenvironment in mismatch-repair proficient colorectal cancer.. Journal of Clinical Oncology. 37(4_suppl). 609–609. 5 indexed citations

Choi, Seo‐Hyun, Michael R. Marco, Raphael Pelossof, et al.. (2019). KRAS mutation is associated with upregulation of integrin beta-4 expression leading to tumor invasion in colorectal cancer.. Journal of Clinical Oncology. 37(4_suppl). 576–576. 1 indexed citations

Marco, Michael R., Lihong Zhou, Sujata Patil, et al.. (2018). Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial. Diseases of the Colon & Rectum. 61(10). 1146–1155. 102 indexed citations

Li, Jiang, Man Chen, Michael R. Marco, et al.. (2013). Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells. Cellular Immunology. 285(1-2). 23–30. 10 indexed citations

Marco, Michael R., Eefje M. Dons, Dirk J. van der Windt, et al.. (2013). Post-transplant repopulation of naïve and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys. Transplant Immunology. 29(1-4). 88–98. 18 indexed citations

10.

Wohl, David A., Michelle A. Kendall, Janet Andersen, et al.. (2009). Low Rate of CMV End-Organ Disease in HIV-Infected Patients Despite Low CD4+ Cell Counts and CMV Viremia: Results of ACTG Protocol A5030. HIV Clinical Trials. 10(3). 143–152. 32 indexed citations

11.

Mariotti, Cesare, F Feliciotti, M. Baldarelli, et al.. (2003). Digital stereotactic biopsies for nonpalpable breast lesion. Surgical Endoscopy. 17(6). 911–917. 7 indexed citations

12.

Marco, Michael R.. (2002). Valganciclovir: a new treatment for cytomegalovirus retinitis.. PubMed. 15(1). 19–21.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact